fda
fda · page 3
- Uncategorized
Bill Aims to Establish Regulatory Framework for CBD as a Supplement
Senator Ron Wyden (D-OR) has reintroduced a bill that aims to establish U.S.
- Markets & Stocks
Cannovum Cannabis AG Announces ‘Outsourcing’ Of Medical Cannabis Business & New CEO, Futura Secures FDA Approval, & Stenocare Reports Q1 Results
Cannovum Cannabis AG [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”27N.DU” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German listed cannabis operator Cannovum Cannabis AG announced this week that it now plans to ‘outsource its existing successful medical business’.
- CBD Market
FDA’s failure to regulate the CBD industry is ‘disrupting public confidence’ in the agency
Cannabis Daily News STOCKS This will be a big test for the cannabis industry Currently, one of the biggest hurdles for multi-state cannabis companies today is that they can’t trade on a major stock exchange due to the U.S. ban on the drug, reports The Motley Fool.
- Hemp Industry
A sneak peek at the Republican-led States Reform Act
The States Reform Act hasn’t been introduced yet, but thanks to Insider, we can take a closer look at what’s being proposed in South Carolina Rep.
- CBD Market
Understanding the CDC warning about Delta-8
The Centers for Disease Control (CDC) and the Food and Drug Administration have issued official health warnings to Americans who are considering or already use Delta-8, a cannabinoid derived from hemp, reports Fast Company.
- CBD Market
Why Can CBD Be A ‘Cure-For-All’ In Europe – But Not The United States?
By Liebe Griebenauw and Peter McCusker FOUR firms have been sanctioned in the latest crackdown by the United States Food and Drug Administration on businesses making medical claims for their CBD products.
- CBD Market
Ground-Breaking Trial With 1,000 CBD Users Aims To Refute Liver Toxicity Claims
TRIALS will start next month in a bid to to assure regulators that oral CBD use is safe.
- Hemp Industry
Meet the Industry with Jonathan Havens of Saul, Ewing, Arnstein & Lehr LLP from MJBizCon 2019
At #MJBizCon2019, Business of Cannabis joined MNP, MGO Ello, Aird + Berlis and the Canadian Securities Exchange inside their Canada’s Cannabis Scene booth to conduct conversations about the state of the industry.
- Your #1 Podcast on Cannabis News
US FDA Approves Epidiolex – What it Means
Jonathan Havens of Saul Ewing Arnstein & Lehr LLP to talk about what the US FDA’s approval of GW Pharma’s Epidiolex CBD-derived product.
